Evershine Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 29-06-2024
- Paid Up Capital ₹ 2.00 M
as on 29-06-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.40 M
as on 29-06-2024
- Revenue 14.83%
(FY 2022)
- Profit 21.08%
(FY 2022)
- Ebitda 129.41%
(FY 2022)
- Net Worth 8.99%
(FY 2022)
- Total Assets 15.75%
(FY 2022)
About Evershine Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.40 M.
Shobha Rani and Shiv Singh serve as directors at the Company.
- CIN/LLPIN
U24232CH2010PTC032204
- Company No.
032204
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Evershine Lifesciences Private Limited offer?
Evershine Lifesciences Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Evershine Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shobha Rani  | Director | 15-Oct-2011 | Current |
| Shiv Singh | Director | 04-May-2010 | Current |
Financial Performance of Evershine Lifesciences.
Evershine Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.83% increase. The company also saw a substantial improvement in profitability, with a 21.08% increase in profit. The company's net worth moved up by a moderate rise of 8.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evershine Lifesciences?
In 2021, Evershine Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Oct 2021 | ₹1.40 M | Open |
How Many Employees Work at Evershine Lifesciences?
Unlock and access historical data on people associated with Evershine Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evershine Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evershine Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
